Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 13, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 177
- −14 vs. Q4 2021
- Portfolio value
- $8.61B
- −$1.09B (−11.2%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | 1,480,253 | $386.3M | 4.5% | −311,508−17.4% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,918,073 | $367.4M | 4.3% | −437,050−4.2% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 953,238 | $300.6M | 3.5% | −43,800−4.4% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,023,451 | $283.4M | 3.3% | −157,100−4.9% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,639,349 | $282.4M | 3.3% | −69,900−4.1% | Reduced | History |
| INCYIncyte Corp | COM | 2,847,400 | $226.1M | 2.6% | −109,600−3.7% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,429,619 | $209.9M | 2.4% | −199,300−5.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 411,637 | $202.2M | 2.3% | −43,657−9.6% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,229,563 | $200.8M | 2.3% | −105,577−7.9% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,622,927 | $192.1M | 2.2% | −122,874−7.0% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 620,068 | $187.1M | 2.2% | +35,605+6.1% | Added | History |
| BSXBoston Scientific Corp | Stock | 3,913,947 | $173.3M | 2.0% | +949,916+32.0% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 305,701 | $155.9M | 1.8% | −6,580−2.1% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,179,253 | $146.7M | 1.7% | −54,150−2.4% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 3,576,486 | $138.7M | 1.6% | −199,250−5.3% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,116,508 | $129.8M | 1.5% | +167,251+17.6% | Added | History |
| AXNXAxonics, Inc. | COM | 2,049,205 | $128.3M | 1.5% | +177,191+9.5% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,129,292 | $120.2M | 1.4% | −220,000−5.1% | Reduced | History |
| DXCMDexcom Inc | COM | 234,900 | $120.2M | 1.4% | −253−0.1% | Reduced | History |
| SYKStryker Corp | Stock | 440,225 | $117.7M | 1.4% | +18,341+4.3% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 754,981 | $117.5M | 1.4% | −131,873−14.9% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,918,962 | $117.3M | 1.4% | −187,000−4.6% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 912,785 | $107.5M | 1.2% | −8,400−0.9% | Reduced | History |
| PODDInsulet Corp | Stock | 398,189 | $106.1M | 1.2% | +15,466+4.0% | Added | History |
| BDXBecton Dickinson & Co | Stock | 396,405 | $105.4M | 1.2% | −59,007−13.0% | Reduced | History |
| DHRDanaher Corp | Stock | 357,062 | $104.7M | 1.2% | −234,738−39.7% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 397,506 | $102.0M | 1.2% | −23,274−5.5% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 3,052,404 | $101.0M | 1.2% | −175,600−5.4% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 302,797 | $101.0M | 1.2% | −11,785−3.7% | Reduced | History |
| AMEDAmedisys Inc | COM | 576,131 | $99.3M | 1.2% | +86,119+17.6% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 3,232,787 | $92.3M | 1.1% | +308,744+10.6% | Added | History |
| OMOutset Medical, Inc. | COM | 2,017,159 | $91.6M | 1.1% | +1,456,553+259.8% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 1,151,159 | $89.9M | 1.0% | +324,418+39.2% | Added | History |
| CDNACareDx, Inc. | COM | 2,311,176 | $85.5M | 1.0% | +844,624+57.6% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 3,310,662 | $84.5M | 1.0% | −159,500−4.6% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 2,612,263 | $84.4M | 1.0% | +2,970+0.1% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 3,551,776 | $83.5M | 1.0% | +30,915+0.9% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 398,577 | $82.6M | 1.0% | −28,033−6.6% | Reduced | History |
| MYOVMyovant Sciences Ltd. | COM | 5,859,039 | $78.0M | 0.9% | −310,000−5.0% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 4,668,148 | $77.6M | 0.9% | −250,000−5.1% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 300,197 | $75.2M | 0.9% | +5,763+2.0% | Added | History |
| Radius Health, Inc.750469207 | COM NEW | 8,318,714 | $73.5M | 0.9% | +550,000+7.1% | Added | – |
| MDTMedtronic plc | Stock | 656,030 | $72.8M | 0.8% | −11,378−1.7% | Reduced | History |
| MGNXMacrogenics Inc | COM | 7,325,514 | $64.5M | 0.7% | −1,234,948−14.4% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 117,810 | $64.4M | 0.7% | −169−0.1% | Reduced | History |
| HUMHumana Inc | Stock | 147,442 | $64.2M | 0.7% | −156,255−51.5% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 90,280 | $63.1M | 0.7% | −2,780−3.0% | Reduced | History |
| CICigna Group | Stock | 259,146 | $62.1M | 0.7% | +13,972+5.7% | Added | History |
| EXELExelixis, Inc. | COM | 2,719,000 | $61.6M | 0.7% | −140,000−4.9% | Reduced | History |
| ALGNAlign Technology Inc | COM | 141,351 | $61.6M | 0.7% | −5,213−3.6% | Reduced | History |
| ACCDAccolade, Inc. | COM | 3,381,507 | $59.4M | 0.7% | +660,132+24.3% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 926,905 | $58.2M | 0.7% | −47,779−4.9% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,098,712 | $55.8M | 0.6% | +448,121+68.9% | Added | History |
| CNCCentene Corp | Stock | 660,635 | $55.6M | 0.6% | +625+0.1% | Added | History |
| GMEDGlobus Medical Inc | Stock | 745,254 | $55.0M | 0.6% | −12,210−1.6% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 311,500 | $50.5M | 0.6% | +4,600+1.5% | Added | History |
| EXASExact Sciences Corp | COM | 719,303 | $50.3M | 0.6% | +76,721+11.9% | Added | History |
| ABMDAbiomed Inc | COM | 150,178 | $49.7M | 0.6% | 00.0% | Unchanged | History |
| OMCLOmnicell, Inc. | COM | 362,332 | $46.9M | 0.5% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 628,128 | $45.9M | 0.5% | −431,219−40.7% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 4,881,752 | $44.4M | 0.5% | +3,328,729+214.3% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 3,145,293 | $43.7M | 0.5% | +1,176,862+59.8% | Added | History |
| SILKSilk Road Medical Inc | COM | 1,045,567 | $43.2M | 0.5% | +93,134+9.8% | Added | History |
| PENPenumbra Inc | COM | 193,654 | $43.0M | 0.5% | −800.0% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 72,633 | $42.9M | 0.5% | −25,695−26.1% | Reduced | History |
| HALOHalozyme Therapeutics, Inc. | COM | 1,024,200 | $40.8M | 0.5% | −43,300−4.1% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 72,009 | $40.6M | 0.5% | +32,326+81.5% | Added | History |
| ATRCAtriCure, Inc. | COM | 598,605 | $39.3M | 0.5% | +100,049+20.1% | Added | History |
| MTEMMolecular Templates, Inc. | COM | 11,078,003 | $38.2M | 0.4% | +200,000+1.8% | Added | History |
| BAXBaxter International Inc | Stock | 489,880 | $38.0M | 0.4% | +40,031+8.9% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 159,120 | $36.8M | 0.4% | −4,400−2.7% | Reduced | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 345,100 | $36.3M | 0.4% | −23,500−6.4% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 126,406 | $35.9M | 0.4% | +60,495+91.8% | Added | History |
| COOCooper Companies, Inc. | COM NEW | 83,216 | $34.8M | 0.4% | −103−0.1% | Reduced | History |
| TFXTeleflex Inc | COM | 97,714 | $34.7M | 0.4% | −57−0.1% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 270,734 | $34.6M | 0.4% | −456−0.2% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 160,601 | $34.1M | 0.4% | −4,354−2.6% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 582,821 | $33.4M | 0.4% | −30,000−4.9% | Reduced | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 1,750,690 | $33.1M | 0.4% | +673,820+62.6% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 5,034,814 | $31.1M | 0.4% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 2,405,825 | $29.8M | 0.3% | +2,405,825 | New | History |
| AXSMAxsome Therapeutics, Inc. | COM | 719,482 | $29.8M | 0.3% | +67,545+10.4% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,184,425 | $28.2M | 0.3% | −110,000−4.8% | Reduced | History |
| ILMNIllumina, Inc. | COM | 78,881 | $27.6M | 0.3% | +3,751+5.0% | Added | History |
| CSTLCastle Biosciences Inc | COM | 607,614 | $27.3M | 0.3% | +607,614 | New | History |
| GBIOGeneration Bio Co. | COM | 3,682,180 | $27.0M | 0.3% | −190,000−4.9% | Reduced | History |
| TDOCTeladoc Health, Inc. | COM | 363,216 | $26.2M | 0.3% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 4,808,401 | $25.9M | 0.3% | +356,708+8.0% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 660,069 | $24.0M | 0.3% | +2,413+0.4% | Added | History |
| CVSCVS Health Corp | Stock | 232,355 | $23.5M | 0.3% | +3,557+1.6% | Added | History |
| HOLXHologic Inc | COM | 275,783 | $21.2M | 0.2% | −303,641−52.4% | Reduced | History |
| RMDResmed Inc | COM | 86,349 | $20.9M | 0.2% | −141−0.2% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,299,164 | $19.9M | 0.2% | −220,000−4.9% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 252,859 | $19.2M | 0.2% | +20,187+8.7% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 111,766 | $19.1M | 0.2% | −1,700−1.5% | Reduced | History |
| AVTRAvantor, Inc. | COM | 512,216 | $17.3M | 0.2% | 00.0% | Unchanged | History |
| NVRONevro Corp | COM | 237,841 | $17.2M | 0.2% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 3,954,000 | $15.8M | 0.2% | −210,000−5.0% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 581,029 | $15.7M | 0.2% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 580,498 | $15.3M | 0.2% | −11,829−2.0% | Reduced | History |
Sold out since Q4 2021 (30)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| VCRAVocera Communications, Inc. | COM | 1,160,613 | $75.3M | 0.8% | History |
| MASIMasimo Corp | COM | 131,376 | $38.5M | 0.4% | History |
| NEONeogenomics Inc | COM NEW | 469,695 | $16.0M | 0.2% | History |
| ZLABZai Lab Ltd | ADR | 126,600 | $7.96M | 0.1% | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 144,957 | $6.87M | 0.1% | History |
| ONCBeOne Medicines Ltd. | ADR | 23,000 | $6.23M | 0.1% | History |
| OSCROscar Health, Inc. | CL A | 679,952 | $5.34M | 0.1% | History |
| CTLTCatalent, Inc. | COM | 23,100 | $2.96M | <0.1% | History |
| DGXQuest Diagnostics Inc | COM | 15,250 | $2.64M | <0.1% | History |
| SYNHSyneos Health, Inc. | CL A | 21,500 | $2.21M | <0.1% | History |
| LLYEli Lilly & Co | Stock | 7,552 | $2.09M | <0.1% | History |
| ZTSZoetis Inc. | Stock | 7,100 | $1.73M | <0.1% | History |
| NVAXNovavax Inc | COM NEW | 10,400 | $1.49M | <0.1% | History |
| CLLSCellectis S.A. | SPON ADS | 82,500 | $670.0K | <0.1% | History |
| LYVLive Nation Entertainment, Inc. | COM | 4,700 | $563.0K | <0.1% | History |
| ENTGEntegris Inc | COM | 3,000 | $416.0K | <0.1% | History |
| MKLMarkel Group Inc. | COM | 300 | $370.0K | <0.1% | History |
| Cyberark Software LtdM2682V108 | SHS | 2,100 | $364.0K | <0.1% | – |
| GGGGraco Inc | COM | 4,500 | $363.0K | <0.1% | History |
| NYTNew York Times Co | CL A | 7,500 | $362.0K | <0.1% | History |
| EAElectronic Arts Inc. | COM | 2,270 | $299.0K | <0.1% | History |
| FTNTFortinet, Inc. | Stock | 803 | $289.0K | <0.1% | History |
| AZPNASPENTECH Corp | COM | 1,874 | $285.0K | <0.1% | History |
| SPOTSpotify Technology S.A. | Stock | 1,100 | $257.0K | <0.1% | History |
| JDJD.com, Inc. | SPON ADS CL A | 3,600 | $252.0K | <0.1% | History |
| AXPAmerican Express Co | Stock | 1,500 | $245.0K | <0.1% | History |
| OLEDUniversal Display Corp | COM | 1,365 | $225.0K | <0.1% | History |
| CLXClorox Co | Stock | 1,200 | $209.0K | <0.1% | History |
| AAgilent Technologies, Inc. | COM | 1,000 | $160.0K | <0.1% | History |
| STNEStoneCo Ltd. | COM | 4,300 | $72.0K | <0.1% | History |